Similar articles for PMID: 17108080

Year	Number of Results
2006	1
2007	4
2008	5
2009	2
2010	9
2011	3
2012	10
2013	6
2014	7
2015	13
2016	9
2017	7
2018	10
2019	10
2020	4
2021	5
2022	3
2024	1

1

A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure.

van Rooij E, Sutherland LB, Liu N, Williams AH, McAnally J, Gerard RD, Richardson JA, Olson EN. van Rooij E, et al. Proc Natl Acad Sci U S A. 2006 Nov 28;103(48):18255-60. doi: 10.1073/pnas.0608791103. Epub 2006 Nov 15. Proc Natl Acad Sci U S A. 2006. PMID: 17108080 Free PMC article.

2

MicroRNAs are dynamically regulated in hypertrophic hearts, and miR-199a is essential for the maintenance of cell size in cardiomyocytes.

Song XW, Li Q, Lin L, Wang XC, Li DF, Wang GK, Ren AJ, Wang YR, Qin YW, Yuan WJ, Jing Q. Song XW, et al. J Cell Physiol. 2010 Nov;225(2):437-43. doi: 10.1002/jcp.22217. J Cell Physiol. 2010. PMID: 20458739

3

MicroRNA-22 regulates cardiac hypertrophy and remodeling in response to stress.

Huang ZP, Chen J, Seok HY, Zhang Z, Kataoka M, Hu X, Wang DZ. Huang ZP, et al. Circ Res. 2013 Apr 26;112(9):1234-43. doi: 10.1161/CIRCRESAHA.112.300682. Epub 2013 Mar 22. Circ Res. 2013. PMID: 23524588 Free PMC article.

4

miR-222 inhibits pathological cardiac hypertrophy and heart failure.

Liu X, Li H, Hastings MH, Xiao C, Damilano F, Platt C, Lerchenmüller C, Zhu H, Wei XP, Yeri A, Most P, Rosenzweig A. Liu X, et al. Cardiovasc Res. 2024 Mar 14;120(3):262-272. doi: 10.1093/cvr/cvad184. Cardiovasc Res. 2024. PMID: 38084908

5

Role of microRNAs in cardiac remodeling and heart failure.

Topkara VK, Mann DL. Topkara VK, et al. Cardiovasc Drugs Ther. 2011 Apr;25(2):171-82. doi: 10.1007/s10557-011-6289-5. Cardiovasc Drugs Ther. 2011. PMID: 21431305 Review.

6

miR-106a promotes cardiac hypertrophy by targeting mitofusin 2.

Guan X, Wang L, Liu Z, Guo X, Jiang Y, Lu Y, Peng Y, Liu T, Yang B, Shan H, Zhang Y, Xu C. Guan X, et al. J Mol Cell Cardiol. 2016 Oct;99:207-217. doi: 10.1016/j.yjmcc.2016.08.016. Epub 2016 Aug 23. J Mol Cell Cardiol. 2016. PMID: 27565029

7

MicroRNA-350 induces pathological heart hypertrophy by repressing both p38 and JNK pathways.

Ge Y, Pan S, Guan D, Yin H, Fan Y, Liu J, Zhang S, Zhang H, Feng L, Wang Y, Xu R, Yin JQ. Ge Y, et al. Biochim Biophys Acta. 2013 Jan;1832(1):1-10. doi: 10.1016/j.bbadis.2012.09.004. Epub 2012 Sep 20. Biochim Biophys Acta. 2013. PMID: 23000971 Free article.

8

Loss of MicroRNA-155 protects the heart from pathological cardiac hypertrophy.

Seok HY, Chen J, Kataoka M, Huang ZP, Ding J, Yan J, Hu X, Wang DZ. Seok HY, et al. Circ Res. 2014 May 9;114(10):1585-95. doi: 10.1161/CIRCRESAHA.114.303784. Epub 2014 Mar 21. Circ Res. 2014. PMID: 24657879 Free PMC article.

9

The miRNA-212/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy.

Ucar A, Gupta SK, Fiedler J, Erikci E, Kardasinski M, Batkai S, Dangwal S, Kumarswamy R, Bang C, Holzmann A, Remke J, Caprio M, Jentzsch C, Engelhardt S, Geisendorf S, Glas C, Hofmann TG, Nessling M, Richter K, Schiffer M, Carrier L, Napp LC, Bauersachs J, Chowdhury K, Thum T. Ucar A, et al. Nat Commun. 2012;3:1078. doi: 10.1038/ncomms2090. Nat Commun. 2012. PMID: 23011132 Free PMC article.

10

lncExACT1 and DCHS2 Regulate Physiological and Pathological Cardiac Growth.

Li H, Trager LE, Liu X, Hastings MH, Xiao C, Guerra J, To S, Li G, Yeri A, Rodosthenous R, Silverman MG, Das S, Ambardekar AV, Bristow MR, González-Rosa JM, Rosenzweig A. Li H, et al. Circulation. 2022 Apr 19;145(16):1218-1233. doi: 10.1161/CIRCULATIONAHA.121.056850. Epub 2022 Feb 4. Circulation. 2022. PMID: 35114812 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year